News
July 14, 2023
Reduce TB cases, Phapros launches Pro TB 2 Daily Dose.
Phapros is launching one of its new products, namely Pro TB 2 Daily Dose. This product comes in a film-coated tablet form and is intended for TB patients....
See MoreJune 21, 2023
69 Years of Phapros' Contribution to the Development of Indonesia's Pharmaceutical Sector
Phapros has achieved in terms of financial performance, contributions to society through the TJSL program, and the production of 500 million units of Blood Enhancing Tablets (TTD)....
See MoreJune 08, 2023
Public Expose: Phapros' (PEHA) 2023 Strategy Focuses on Innovative Business Development, Digitalization, and Human Resources Development
Phapros held its Annual General Meeting of Shareholders for the 2022 fiscal year, followed by a public expose by the company...
See MoreMay 31, 2023
Phapros Expands Product Development Through Collaboration and Innovation
Phapros is currently undertaking product development initiatives through strategic collaborations with various parties, including its subsidiary PT Lucas Djaja, as well as domestic n global....
See MoreMay 23, 2023
Digitalization of Technology Becomes the Solution for the Pharmaceutical Industry
Digital transformation has become a necessity in today's industrial world, especially in the pharmaceutical sector....
See MoreApril 28, 2023
Phapros recorded 8.9% growth for its ethical products in the first quarter of 2023.
Phapros CEO, Hadi Kardoko, stated that the growth of Phapros' branded prescription drugs (ethical products) in the first quarter of 2023 increased by 8.9% compared to the previous year....
See More